These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


580 related items for PubMed ID: 22415073

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Apolipoprotein A5 alleviates LPS/D-GalN-induced fulminant liver failure in mice by inhibiting TLR4-mediated NF-κB pathway.
    Tao YC, Wang ML, Wu DB, Luo C, Tang H, Chen EQ.
    J Transl Med; 2019 May 10; 17(1):151. PubMed ID: 31077206
    [Abstract] [Full Text] [Related]

  • 3. Protective effect of linarin against D-galactosamine and lipopolysaccharide-induced fulminant hepatic failure.
    Kim SJ, Cho HI, Kim SJ, Park JH, Kim JS, Kim YH, Lee SK, Kwak JH, Lee SM.
    Eur J Pharmacol; 2014 Sep 05; 738():66-73. PubMed ID: 24877692
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. CQMUH-011, a novel adamantane sulfonamide compound, inhibits lipopolysaccharide- and D-galactosamine-induced fulminant hepatic failure in mice.
    Yan L, Hu X, Wu Q, Jiang R, Zhang S, Ling Q, Liu H, Jiang X, Wan J, Liu Y.
    Int Immunopharmacol; 2017 Jun 05; 47():231-243. PubMed ID: 28433945
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Emodin ameliorated lipopolysaccharide-induced fulminant hepatic failure by blockade of TLR4/MD2 complex expression in D-galactosamine-sensitized mice.
    Yin X, Gong X, Jiang R, Kuang G, Wang B, Zhang L, Xu G, Wan J.
    Int Immunopharmacol; 2014 Nov 05; 23(1):66-72. PubMed ID: 25173984
    [Abstract] [Full Text] [Related]

  • 10. Pretreatment of lipopolysaccharide (LPS) ameliorates D-GalN/LPS induced acute liver failure through TLR4 signaling pathway.
    Zhang S, Yang N, Ni S, Li W, Xu L, Dong P, Lu M.
    Int J Clin Exp Pathol; 2014 Nov 05; 7(10):6626-34. PubMed ID: 25400741
    [Abstract] [Full Text] [Related]

  • 11. Sesamin ameliorates lipopolysaccharide/d-galactosamine-induced fulminant hepatic failure by suppression of Toll-like receptor 4 signaling in mice.
    Ma L, Gong X, Kuang G, Jiang R, Chen R, Wan J.
    Biochem Biophys Res Commun; 2015 May 29; 461(2):230-6. PubMed ID: 25866179
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. NLRP3 inflammasome activation in D-galactosamine and lipopolysaccharide-induced acute liver failure: role of heme oxygenase-1.
    Kim SJ, Lee SM.
    Free Radic Biol Med; 2013 Dec 29; 65():997-1004. PubMed ID: 23994575
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Modulation of the crosstalk between Keap1/Nrf2/HO-1 and NF-κB signaling pathways by Tomatidine protects against inflammation/oxidative stress-driven fulminant hepatic failure in mice.
    Abdulaal WH, Omar UM, Zeyadi M, El-Agamy DS, Alhakamy NA, Ibrahim SRM, Almalki NAR, Asfour HZ, Al-Rabia MW, Mohamed GA, Elshal M.
    Int Immunopharmacol; 2024 Mar 30; 130():111732. PubMed ID: 38402834
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hepatoprotective Effects of Kaempferol-3-O-α-l-Arabinopyranosyl-7-O-α-l-Rhamnopyranoside on d-Galactosamine and Lipopolysaccharide Caused Hepatic Failure in Mice.
    Dong L, Yin L, Quan H, Chu Y, Lu J.
    Molecules; 2017 Oct 18; 22(10):. PubMed ID: 29057809
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 29.